Mink therapeutics to present inkt cell therapy in gastric cancer at asco gi annual meeting

Presentation will feature the ongoing phase 2 study of agent-797 in refractory gastric cancer presentation will feature the ongoing phase 2 study of agent-797 in refractory gastric cancer

INKT Ratings Summary

INKT Quant Ranking